Clinical Trial Update: Prednisone Reduction in ICU Patients With COPD Exacerbation [Phase 4]

View source ↗

Summary

Phase 4 trial update examining prednisone reduction in ICU COPD exacerbation patients on mechanical ventilation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COPD Exacerbation
• Chronic Obstructive Pulmonary Disease
• Respiratory Failure Due to COPD

Drugs mentioned

• PREDNISONE (Prednisone)

Snippet

Sponsor: Hôpital Universitaire Fattouma Bourguiba | Conditions: Copd Exacerbation Acute, Mechanical Ventilation | Phase 4 | Status: UNKNOWN